Three patients were evaluated for refractory digital ischemia. The first patient presented with chronic, post-traumatic, unremitting, cold, painful, right fourth and fifth fingers. The symptoms had failed to improve despite topical nitroglycerin and a calcium channel blocker. Baseline digital plethysmography documented impaired perfusion within the affected digits. Cilostazol (Pletal  ) was added to the medical regimen and at the 8-week follow-up the fourth and fifth fingers were warm with repeat plethysmography displaying normal perfusion. A second patient had CREST syndrome-associated painful bilateral index finger ulcerations that had evolved despite taking a calcium channel blocker. Consequently the patient was started on cilostazol and within 4 weeks the digital ulcerations and pain had resolved. The third patient with traumatic right fifth digital arterial thrombosis was seen for persistent pain and cyanosis in spite of undergoing thrombolysis and subsequent anticoagulation with vasodilator therapy. Digital plethysmography established fixed ischemia within the fifth finger; subsequently, cilostazol was prescribed. Four weeks later the digital pain and cyanosis had essentially resolved. A follow-up plethysmographic waveform documented restored perfusion. Although approved for the treatment of intermittent claudication, cilostazol was successfully utilized in the setting of severe digital ischemia.
A 39-year-old right-handed auto mechanic presented in March 2000 for evaluation of persistently cold, painful, right fourth and fifth digits. The past medical history was unremarkable. The patient had smoked one pack of cigarettes per day for the last ten years.
Five months prior to his presentation the patient punched a door with his right hand. Within 24 h he developed unremitting coldness, pain, and pallor within the right fourth and fifth fingers. Although the patient admitted to the longstanding work-related use of vibrational tools, mallets, and forcefully striking the ulnar surface of his hands on hubcaps, he denied a premorbid history of digital vasospasm or dysesthesias. At the outset, the referring physician prescribed topical nitroglycerin ointment three times daily and felodipine 5 mg daily. Despite vasodilator therapy, the digital coldness persisted and a vascular evaluation was requested.
On examination the brachial systolic pressures were symmetric. The right fourth and fifth fingers were uniformly cool and pallorous. No digital ulcerations were present, although splinter hemorrhages were noted within the fourth digit nail bed. The remaining digits were well perfused. The brachial and radial pulses were 2+/2 bilaterally. Allen's test on the right was positive for diminished flow within the distal ulnar artery/superficial palmar arch distribution. Non-invasive arterial studies displayed sym-metric pressures and triphasic waveforms over the brachial, radial, and ulnar arteries. A digital plethysmographic study obtained after 10 min of external warming documented dampened right fourth and fifth digit waveforms ( Figure  1A) .
A presumptive diagnosis of traumatic distal ulnar artery and superficial palmar arch thrombosis with digital arterial emboli was made (probable hypothenar hammer syndrome). The patient refused arteriography. Topical nitroglycerin was discontinued and a trial of cilostazol (Pletal  ) at a dose of 50 mg twice daily was utilized (dose adjusted due to the use of felodipine). Tobacco cessation was recommended but declined. Within several weeks, the patient noted subjectively warmer, less painful fingers with only mild paroxysmal vasospasm. At the 8-week followup, the affected digits were no longer pallorous and were palpably warm. A repeat digital plethysmographic study illustrated normal, pulsatile, right fourth and fifth waveforms ( Figure 1B) . At the 6-and 12-month follow-ups, the patient continued to take cilostazol plus felodipine and described only intermittent insignificant right fourth and fifth digital vasospasm.
Case number 2
A 47-year-old male presented in April 2001 for evaluation of persistently cold, painful, bilateral index fingers. His past medical history was remarkable for hypertension, hypothyroidism, and recently diagnosed CREST syndrome (ANA 1:1280 with anticentromere staining). He had smoked one pack of cigarettes per day for the last 26 years.
The patient related a longstanding history of episodic digital cold sensitivity and swelling but denied attendant color changes. Four months prior to his presentation, his bilateral index fingers became persistently cold, discolored, and painful with distal ulcerations. He denied antecedent trauma to the digits and did not use vibrational tools. Although the patient had been taking felodipine 10 mg daily for the last 5 years, it had been prescribed for hypertension and not vasospastic disease.
On examination the brachial systolic pressures were symmetric. Shallow, necrotic ulcerations were present on the tufts of the bilateral index fingers, which were diffusely cool and mildly cyanotic. A small depressed pit was also identified on the distal portion of the left index finger (Figures 2 A and B ). All of his fingers were slightly edematous. The brachial and radial pulses were 2+/2 bilaterally. Allen's test was negative bilaterally. Non-invasive arterial studies displayed symmetric pressures and triphasic waveforms over the brachial, radial, and ulnar arteries. Digital plethysmographic studies obtained after 10 min of external warming showed severely dampened (essentially flat) waveforms from the bilateral index fingers, mildly dampened waveforms from the bilateral ring fingers, and normal pulsatility from the remaining digits.
CREST syndrome-associated digital ischemia was diagnosed. Since the patient had developed ischemic ulcerations despite using high-dose felodipine for his hypertension, cilostazol was started at a dose of 50 mg twice daily (dose adjusted due to felodipine). The patient was unable to stop smoking. Within several weeks, the patient noted subjectively warmer, less painful index fingers as well as a 
Case number 3
A 46-year-old right-handed anesthesiologist presented in May 2001 for evaluation of painful, cold, mottled, right fourth and fifth fingers. His past medical history was noncontributory and he did not smoke.
Ten days prior to presentation, the patient had used the palmar surface of his right hand to place a stake in the ground. Over the next 24 h he developed painful, dysesthetic, cold, right fourth and fifth fingers. The patient denied a prior history of similar symptoms or of Raynaud phenomenon; however, he did relate occasionally using the right hand to place stakes in the ground.
On examination the brachial systolic pressures were symmetric. The right fourth and fifth fingers were visibly mottled, cool and pallorous. No digital ulcerations or splinter hemorrhages were identified. Mottling was also present on the ulnar portion of the palm. The remaining digits were well perfused. The brachial and radial pulses were 2+/2 bilaterally. The right ulnar pulse was non-palpable. Allen's test on the right was positive for diminished flow within the distal ulnar artery/superficial palmar arch distribution.
The patient underwent immediate arteriography, which documented an occluded right distal ulnar artery distal with thrombus within the superficial palmar arch plus the fourth and fifth digital arteries. Catheter-directed thrombolysis, heparin, and nitroglycerin were used for approximately 24 h. Although the completion arteriogram still documented occluded ulnar and distal fifth digital arteries, improved perfusion was identified within the superficial palmar arch and fourth digital arteries. After thrombolysis, the fourth finger was well perfused. The proximal portion of the fifth finger was warm as well; however, the distal portion remained palpably cool and partially mottled. The patient was discharged on a regimen of warfarin and nifedipine XL 30 mg daily.
At the 1-week follow-up, the patient's only complaints were intermittent vasospasm and persistent, focal, purplish discoloration involving the right fifth finger, which was still mildly cool to palpation ( Figure 3A) . A post-lysis digital plethysmographic study obtained after 10 min of external warming documented a moderately dampened right fifth digit waveform. The remaining digit waveforms were normal ( Figure 4A ). At that time, cilostazol 50 mg twice daily (dose adjusted due to nifedipine) was added to his pharmacological regimen.
Approximately 10 days after cilostazol was added, the patient's fifth finger discoloration and vasospasm had essentially resolved. At the 4-week follow-up, the right fifth digit was warm and no longer discolored ( Figure 3B ). In addition, a repeat post-warming plethysmographic study displayed normal fifth finger perfusion ( Figure 4B ). 
Discussion
Cilostazol is a phosphodiesterase III inhibitor that exhibits antiplatelet, antithrombotic, and vasodilatory properties. However, its precise mechanism of action remains incompletely defined. Although approved by the Food and Drug Administration in 1999 as a new treatment option for intermittent claudication, cilostazol may ameliorate the complications of Raynaud phenomenon, including vasospasm and ulcerations. In a non-placebo controlled trial of 25 patients with Raynaud phenomenon from a variety of causes (systemic lupus erythematosus, systemic sclerosis, Sjögren's syndrome, mixed connective tissue disease, and idiopathic), 36% of subjects experienced moderate to marked improvement in their vasospastic symptoms with cilostazol (100 mg/day). In addition, digital skin temperatures were measured before and after therapy and documented an increased post-treatment fingertip temperature for the overall population from 31.68 to 32.20 ± 0.23°C (p Ͻ 0.01). 1 Tsuru et al treated 15 patients with collagen vascular disease (CVD)-associated Raynaud's phenomenon with cilostazol 200 mg/day for 4 weeks. At the end of therapy, 53% of the subjects had improved symptoms. 2 During an 8-week investigation of 24 patients with CVD-associated digital ulcerations, 88% of patients experienced a decrease in ulcer-associated pain and size with cilostazol (100 mg/day). 3 All three patients in our case series experienced either suboptimal or no improvement in their digital ischemia despite vasodilator therapy with a dihydropyridine calcium channel antagonist. Adjunctive therapy with either topical nitroglycerin or warfarin also failed to improve the digital perfusion in the two cases with traumatic digital ischemia. However, within 2 weeks of beginning cilostazol all patients noted subjectively warmer digits. Objectively improved digital perfusion with cilostazol was documented by plethysmographic waveforms in the two patients with prior hand and digital trauma. To the best of our knowledge, cilostazol has not been investigated in the setting of traumatic digital ischemia. In addition, the CREST syndrome patient's bilateral index finger ulcers and left-sided pit healed after 4 weeks of cilostazol therapy. As noted above, previous studies have documented that 36-88% of patients with CVD-associated digital ulcerations improved with cilostazol therapy. [1] [2] [3] Last of all, even concurrent tobacco use did not negate the beneficial effects of cilostazol in the two patients who refused to discontinue smoking.
There are several potential limitations of our case series that could affect the validity of the results. First, all of the patients received cilostazol therapy in the setting of slightly increasing ambient temperature. However, since all subjects reported clinical improvement within just 2 weeks of beginning the medication, it is less likely that a minimal favorable climatic change rapidly restored digital perfusion. Secondly, since our study was not placebo controlled, the possibility of spontaneous improvement in digital perfusion cannot be excluded.
Vascular Medicine 2001; 6: [245] [246] [247] [248] Larger, placebo-controlled studies examining the use of cilostazol in the setting of digital arterial vasospasm and intrinsic small vessel disease are warranted.
